Skip to main content
Funded Studies

Philip LoGrasso, PhD

Professor, Molecular Therapeutics; Senior Director Drug Discovery at The Scripps Research Institute

Location: Jupiter, FL United States

Dr. LoGrasso is a professor in the Molecular Therapeutics Department and senior director of drug discovery within The Scripps Research Institute, where he has been since 2005. Prior to joining Scripps, Dr. LoGrasso was a program officer at NIGMS and had responsibility for funding a $50MM research portfolio in the areas of chemical biology, medicinal chemistry, and pharmacology.

In his last industrial position, Dr. LoGrasso was the director of pre-clinical research and development at Avera Pharmaceuticals. In this role, he placed two compounds into Phase II clinical development for CNS disorders. Prior to Avera, he was a research fellow at Merck Research Laboratories for nearly nine years, working in the areas of inflammation and neuroscience. In this capacity he was responsible for evaluation of pre-clinical drug candidates and novel target discovery targets. His research focus was on MAP-kinase signal transduction pathways and associated mechanistic enzymology, inhibitor characterization, and structure-function relationships.

Associated Grants

  • Probing the Function of SGK1 and its Relationship to LRRK2 and Parkinson’s Disease


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.